SFRS17A 抗体 (AA 475-525)
Quick Overview for SFRS17A 抗体 (AA 475-525) (ABIN7449820)
抗原
See all SFRS17A (AKAP17A) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 475-525
- 
                                            原理
- Rabbit anti-SFRS17A Antibody, Affinity Purified
- 
                                            纯化方法
- Affinity Purified
- 
                                            免疫原
- between AA 475 and 525
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        IP: 2 - 10 μg/mg lysate WB: 1:1,000 - 1:5,000 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            浓度
- 1000 μg/mL
- 
                                            缓冲液
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - SFRS17A (AKAP17A) (A Kinase (PRKA) Anchor Protein 17A (AKAP17A))
- 
                                            别名
- SFRS17A
- 
                                            背景
- Background: Splicing factor, arginine/serine-rich 17A (SFRS17A) is involved in regulating alternative splice site selection for certain mRNA precursors. SFRS17A mediates regulation of pre-mRNA splicing in a PKA-dependent manner.
- 
                                            基因ID
- 8227
- 
                                            NCBI登录号
- NP_005079
- 
                                            UniProt
- Q02040
 抗原
- 
                    
 
                                     
                                     
                                    